Aurinia Pharmaceuticals Inc (AUPH)

[Zeppo]

Slim.....I don't know anything you don't know. I am just looking at the timing of the recent events. The NDA gets filed, and then the offering quickly follows. Why? The market, overall, has rebuilt itself and is now closer to its all time highs. Sentiment is more positive. The Phase III test result was a powerful specimen. The company says we'll have an answer by the end of January....yet it could come sooner. I believe that cash readiness also is an issue. A quicker approval could trigger, at the very least, a strategic alliance to catapult the launch. That's all: no rocket science or insider info here.